Literature DB >> 11017924

The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils.

S E Lavens-Phillips1, D W MacGlashan.   

Abstract

Within the general population, individuals can be found whose basophils do not secrete after stimulation through the immunoglobulin (Ig) E receptor. In this study we compared two groups of donors, those whose basophils responded with 65+/-16% histamine release to an optimal concentration of anti-IgE antibody and those whose basophil response was not statistically different from nonstimulated release (1+/-1%). We show that these so-called nonreleasing basophils have at least 10-fold lower expression of the tyrosine kinases, lyn and syk, but normal expression of the tyrosine kinase Btk when compared with the panel of releasing basophils. Indeed, maximum histamine release correlated with expression of both syk (Spearman rank correlation coefficient [Rs] = 0.98) and lyn (Rs = 0.93). In contrast, equivalent levels of messenger RNA (mRNA) for lyn and syk kinase were found for both groups. By sequencing a critical region in the syk mRNA, our results also demonstrate that the frame shift mutation in syk leading to a premature stop codon which has been observed in other cell types is not present in nonreleasing human basophils. Our results suggest that there may be translational or post-translational regulatory mechanisms specific to the expression of two important FcepsilonRI-associated signaling elements in basophils.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017924     DOI: 10.1165/ajrcmb.23.4.4123

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

Review 1.  Assessing basophil functional measures during monoclonal anti-IgE therapy.

Authors:  Sarbjit S Saini; Donald W MacGlashan
Journal:  J Immunol Methods       Date:  2012-06-01       Impact factor: 2.303

2.  Syk deficiency in human non-releaser lung mast cells.

Authors:  Gregorio Gomez; Lawrence Schwartz; Christopher Kepley
Journal:  Clin Immunol       Date:  2007-08-10       Impact factor: 3.969

Review 3.  New approaches to allergen immunotherapy.

Authors:  Christopher L Kepley
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

4.  Stability of Syk protein and mRNA in human peripheral blood basophils.

Authors:  Donald MacGlashan
Journal:  J Leukoc Biol       Date:  2016-03-15       Impact factor: 4.962

5.  Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor.

Authors:  Donald MacGlashan; Lee A Honigberg; Ashley Smith; Joseph Buggy; John T Schroeder
Journal:  Int Immunopharmacol       Date:  2011-01-14       Impact factor: 4.932

6.  Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab.

Authors:  Asifa K Zaidi; Sarbjit S Saini; Donald W Macglashan
Journal:  J Allergy Clin Immunol       Date:  2010-03-17       Impact factor: 10.793

7.  Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34-derived basophils.

Authors:  Susan S Ishmael; Donald W MacGlashan
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

8.  Histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced histamine release is enhanced with SHIP-1 knockdown in cultured human mast cell and basophil models.

Authors:  Jacqueline M Langdon; John T Schroeder; Becky M Vonakis; Anja P Bieneman; Kristin Chichester; Susan M Macdonald
Journal:  J Leukoc Biol       Date:  2008-07-14       Impact factor: 4.962

9.  Development of a microarray-based method to detect exposure of human basophils to IL-3.

Authors:  Donald MacGlashan
Journal:  J Immunol Methods       Date:  2012-08-14       Impact factor: 2.303

10.  Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation.

Authors:  Nicolas Charles; Wendy T Watford; Haydeé L Ramos; Lars Hellman; Hans C Oettgen; Gregorio Gomez; John J Ryan; John J O'Shea; Juan Rivera
Journal:  Immunity       Date:  2009-04-09       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.